Review





Similar Products

ca9 22  (ATCC)
97
ATCC ca9 22
Ca9 22, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca9 22/product/ATCC
Average 97 stars, based on 1 article reviews
ca9 22 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

94
Sino Biological human caix protein
Human Caix Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human caix protein/product/Sino Biological
Average 94 stars, based on 1 article reviews
human caix protein - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

95
Proteintech primary antibodies ca9
Primary Antibodies Ca9, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies ca9/product/Proteintech
Average 95 stars, based on 1 article reviews
primary antibodies ca9 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Proteintech rabbit polyclonal anti ca9
Rabbit Polyclonal Anti Ca9, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti ca9/product/Proteintech
Average 95 stars, based on 1 article reviews
rabbit polyclonal anti ca9 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Proteintech anti ca ix
Anti Ca Ix, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ca ix/product/Proteintech
Average 95 stars, based on 1 article reviews
anti ca ix - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

95
Proteintech ca9
Ca9, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ca9/product/Proteintech
Average 95 stars, based on 1 article reviews
ca9 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

97
Thermo Fisher gene exp ca9 hs00154208 m1
Mutant IDH1 and hypoxia induce DNA damage synergistically in IHA. A) GSEA analyses of significantly enriched gene sets related to angiogenesis. Blue dotted box: pathways related to mitotic activities. Red dotted box: pathways related to vasculature regulation. B) Comparison of average expression of 26 genes in IDHwt and IDHmut tumors. C) Kaplan‐Meier analysis comparing overall survival in angiogenesis score‐high and ‐low patients. P values were determined by the log‐rank (Mantel‐Cox) test. D) Western blot analysis of HIF‐1α and EZH2 (loading control) under hypoxia (1% O 2 ). Experiments were repeated three times, and the average signal intensity was plotted on bar graphs as mean ± SEM. N = 3. E) mRNA transcript abundance of LDHA, PDK1, PGK1, SLC2A1, VEGFA, and <t>CA9</t> (internal control) was determined by Real‐time PCR and plotted on bar graphs as mean ± SEM. N = 4. F) Relative intracellular 2‐HG level in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions measured by LC‐MS. N = 3. G) Immunofluorescence staining of γ‐H 2 AX (green) in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Blue: DAPI. Scale bar represents 10 µm. H). Ten independent fields were quantified, and the percentage of average γ‐H 2 AX foci in the nucleus was plotted. N = 10. I) Neutral Comet assays determining DNA breaks in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Scale bar represents 200 µm. J). The length of comet tails was quantified and represented on the plot. N = 20. K) propidium iodide (PI) positivity of IHA‐EV and IHA‐IDH1mut, treated with veliparib (20 µM) and hypoxia (1% O 2 ) was determined by flow cytometry, quantified, and plotted. N = 4. L) Clonogenic survival assays of IHA‐EV and IHA‐IDH1mut cells under the indicated conditions. The colonies were quantified and represented on the bar graph showing the synergistic effect of veliparib and hypoxia, specifically in IHA‐IDH1mut cells. N = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not significant.
Gene Exp Ca9 Hs00154208 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp ca9 hs00154208 m1/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
gene exp ca9 hs00154208 m1 - by Bioz Stars, 2026-02
97/100 stars
  Buy from Supplier

95
Proteintech antibodies against human ca9
Mutant IDH1 and hypoxia induce DNA damage synergistically in IHA. A) GSEA analyses of significantly enriched gene sets related to angiogenesis. Blue dotted box: pathways related to mitotic activities. Red dotted box: pathways related to vasculature regulation. B) Comparison of average expression of 26 genes in IDHwt and IDHmut tumors. C) Kaplan‐Meier analysis comparing overall survival in angiogenesis score‐high and ‐low patients. P values were determined by the log‐rank (Mantel‐Cox) test. D) Western blot analysis of HIF‐1α and EZH2 (loading control) under hypoxia (1% O 2 ). Experiments were repeated three times, and the average signal intensity was plotted on bar graphs as mean ± SEM. N = 3. E) mRNA transcript abundance of LDHA, PDK1, PGK1, SLC2A1, VEGFA, and <t>CA9</t> (internal control) was determined by Real‐time PCR and plotted on bar graphs as mean ± SEM. N = 4. F) Relative intracellular 2‐HG level in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions measured by LC‐MS. N = 3. G) Immunofluorescence staining of γ‐H 2 AX (green) in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Blue: DAPI. Scale bar represents 10 µm. H). Ten independent fields were quantified, and the percentage of average γ‐H 2 AX foci in the nucleus was plotted. N = 10. I) Neutral Comet assays determining DNA breaks in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Scale bar represents 200 µm. J). The length of comet tails was quantified and represented on the plot. N = 20. K) propidium iodide (PI) positivity of IHA‐EV and IHA‐IDH1mut, treated with veliparib (20 µM) and hypoxia (1% O 2 ) was determined by flow cytometry, quantified, and plotted. N = 4. L) Clonogenic survival assays of IHA‐EV and IHA‐IDH1mut cells under the indicated conditions. The colonies were quantified and represented on the bar graph showing the synergistic effect of veliparib and hypoxia, specifically in IHA‐IDH1mut cells. N = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not significant.
Antibodies Against Human Ca9, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against human ca9/product/Proteintech
Average 95 stars, based on 1 article reviews
antibodies against human ca9 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

Image Search Results


Mutant IDH1 and hypoxia induce DNA damage synergistically in IHA. A) GSEA analyses of significantly enriched gene sets related to angiogenesis. Blue dotted box: pathways related to mitotic activities. Red dotted box: pathways related to vasculature regulation. B) Comparison of average expression of 26 genes in IDHwt and IDHmut tumors. C) Kaplan‐Meier analysis comparing overall survival in angiogenesis score‐high and ‐low patients. P values were determined by the log‐rank (Mantel‐Cox) test. D) Western blot analysis of HIF‐1α and EZH2 (loading control) under hypoxia (1% O 2 ). Experiments were repeated three times, and the average signal intensity was plotted on bar graphs as mean ± SEM. N = 3. E) mRNA transcript abundance of LDHA, PDK1, PGK1, SLC2A1, VEGFA, and CA9 (internal control) was determined by Real‐time PCR and plotted on bar graphs as mean ± SEM. N = 4. F) Relative intracellular 2‐HG level in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions measured by LC‐MS. N = 3. G) Immunofluorescence staining of γ‐H 2 AX (green) in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Blue: DAPI. Scale bar represents 10 µm. H). Ten independent fields were quantified, and the percentage of average γ‐H 2 AX foci in the nucleus was plotted. N = 10. I) Neutral Comet assays determining DNA breaks in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Scale bar represents 200 µm. J). The length of comet tails was quantified and represented on the plot. N = 20. K) propidium iodide (PI) positivity of IHA‐EV and IHA‐IDH1mut, treated with veliparib (20 µM) and hypoxia (1% O 2 ) was determined by flow cytometry, quantified, and plotted. N = 4. L) Clonogenic survival assays of IHA‐EV and IHA‐IDH1mut cells under the indicated conditions. The colonies were quantified and represented on the bar graph showing the synergistic effect of veliparib and hypoxia, specifically in IHA‐IDH1mut cells. N = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not significant.

Journal: Advanced Science

Article Title: Prickle4 Drives Microenvironmental Remodeling and Resistance to Parp Inhibition in IDH‐Mutant Glioma

doi: 10.1002/advs.202503866

Figure Lengend Snippet: Mutant IDH1 and hypoxia induce DNA damage synergistically in IHA. A) GSEA analyses of significantly enriched gene sets related to angiogenesis. Blue dotted box: pathways related to mitotic activities. Red dotted box: pathways related to vasculature regulation. B) Comparison of average expression of 26 genes in IDHwt and IDHmut tumors. C) Kaplan‐Meier analysis comparing overall survival in angiogenesis score‐high and ‐low patients. P values were determined by the log‐rank (Mantel‐Cox) test. D) Western blot analysis of HIF‐1α and EZH2 (loading control) under hypoxia (1% O 2 ). Experiments were repeated three times, and the average signal intensity was plotted on bar graphs as mean ± SEM. N = 3. E) mRNA transcript abundance of LDHA, PDK1, PGK1, SLC2A1, VEGFA, and CA9 (internal control) was determined by Real‐time PCR and plotted on bar graphs as mean ± SEM. N = 4. F) Relative intracellular 2‐HG level in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions measured by LC‐MS. N = 3. G) Immunofluorescence staining of γ‐H 2 AX (green) in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Blue: DAPI. Scale bar represents 10 µm. H). Ten independent fields were quantified, and the percentage of average γ‐H 2 AX foci in the nucleus was plotted. N = 10. I) Neutral Comet assays determining DNA breaks in IHA‐EV and IHA‐IDH1mut under hypoxic and non‐hypoxic conditions. Scale bar represents 200 µm. J). The length of comet tails was quantified and represented on the plot. N = 20. K) propidium iodide (PI) positivity of IHA‐EV and IHA‐IDH1mut, treated with veliparib (20 µM) and hypoxia (1% O 2 ) was determined by flow cytometry, quantified, and plotted. N = 4. L) Clonogenic survival assays of IHA‐EV and IHA‐IDH1mut cells under the indicated conditions. The colonies were quantified and represented on the bar graph showing the synergistic effect of veliparib and hypoxia, specifically in IHA‐IDH1mut cells. N = 3. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns: not significant.

Article Snippet: For transcript quantification, real‐time RT‐PCR was performed as described(Andersen et al, 2004) with the following Taqman probes: Ldha (ThermoFisher, Hs01378790_g1), Pdk1 (Hs01561847_m1), Pgk1 (Hs00943178_g1), Slc2a1 (Hs00892681_m1), Vegfa (Hs00900055_m1) and Ca9 (Hs00154208_m1) as internal control; for mouse tumors, Kdm5a (Mm00524457_m1), Prickle4 (Mm04933143_m1), Ddx3y (Mm00465349_m1), Ccl24 (Mm00444700_g1) and Esr1 (Mm00433149_m1) as internal control.

Techniques: Mutagenesis, Comparison, Expressing, Western Blot, Control, Real-time Polymerase Chain Reaction, Liquid Chromatography with Mass Spectroscopy, Immunofluorescence, Staining, Flow Cytometry